江西同和药业

Jiangxi Tonghe Pharmaceutical is a leading Chinese manufacturer specializing in the research, development, and production of Active Pharmaceutical Ingredients (APIs) and advanced chemical intermediates. Established in 2004 and headquartered in Jiangxi Province, the company operates high-standard manufacturing facilities that comply with international GMP regulations, including those of the US FDA, EMA, and PMDA. Its product portfolio primarily targets the central nervous system, cardiovascular, and digestive therapeutic areas, with key products including Gabapentin, Pregabalin, and Rivaroxaban. In addition to its generic API business, Tonghe Pharma provides CDMO services to global pharmaceutical innovators, leveraging its expertise in complex small molecule synthesis. The company is publicly traded on the Shenzhen Stock Exchange and maintains a strong export focus, serving markets in Europe, North America, and Japan.